<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04453683</url>
  </required_header>
  <id_info>
    <org_study_id>Intubation in morbid obese</org_study_id>
    <nct_id>NCT04453683</nct_id>
  </id_info>
  <brief_title>Airway Management in Morbidly Obese Patients: A Comparison Between Fiber Optic-guided Intubating Laryngeal Mask and Air Q</brief_title>
  <official_title>Airway Management in Morbidly Obese Patients: A Comparison Between Intubating Laryngeal Mask and Air Q in Conjunction With Fiberoptic Bronchoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare air Q versus ILMA intubation in obese adult paralyzed patient
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluate the process of endo-tracheal intubation through Air Q compared to through ILMA
      regarding number and duration of attempts, laryngeal view grade, time to removal of device
      over tube without dislodgement and any complication
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 20, 2019</start_date>
  <completion_date type="Actual">June 20, 2020</completion_date>
  <primary_completion_date type="Actual">June 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success rate of tracheal intubation through each device.</measure>
    <time_frame>Within a maximum of 5 minutes to confirm success of tracheal intubation through each supraglottic airway devices</time_frame>
    <description>success rate of tracheal intubation through each device is defined as end tidal carbon dioxide confirmed placement of TT within a maximum of 5 min tracheal intubation time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insertion time of supraglottic airway devices</measure>
    <time_frame>It is about 13-19 second for insertion of supraglottic airway devices</time_frame>
    <description>Time necessary for insertion was measured from the time the face mask was taken away until the appearance of Co2 on the capnograph while supraglottic airway device in place</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Intubation; Difficult or Failed</condition>
  <arm_group>
    <arm_group_label>Group I ( Air Q)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>nsertion of proper size Air-Q. ILA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (ILMA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>nsertion of proper size ILMA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Air-Q. ILA insertion of proper size</intervention_name>
    <description>Success of fiberoptic guided intubation throuhgh Air Q supraglottic airway device</description>
    <arm_group_label>Group I ( Air Q)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ILMA insertion of proper size</intervention_name>
    <description>Success of fiberoptic guided intubation throuhgh ILMA supraglottic airway device</description>
    <arm_group_label>Group II (ILMA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:All morbidly obese patient defined as BMI &gt;40 kg/m2 scheduled for an
        elective surgery requiring general anesthesia with tracheal intubation were enrolled on the
        day of their surgery.

        ASA physical status (I-II)

        Exclusion Criteria physical status of IV or V or had a history of impossible tracheal
        intubation or awake fibreoptic intubation or if preoperative evaluation showed limited
        mouth aperture &lt;3.5 cm or showed evidence that an awake fiberoptic intubation or rapid
        sequence induction would be required patients at increased risk for aspiration of gastric
        contents, coagulopathy or those with unstable cervical spines or requiring nasal route for
        tracheal intubation

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heba M EL-Asser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heba M Heba, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zagazig University</name>
      <address>
        <city>Zagazig</city>
        <zip>002055</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Frappier J, Guenoun T, Journois D, Philippe H, Aka E, Cadi P, Silleran-Chassany J, Safran D. Airway management using the intubating laryngeal mask airway for the morbidly obese patient. Anesth Analg. 2003 May;96(5):1510-5, table of contents.</citation>
    <PMID>12707159</PMID>
  </reference>
  <reference>
    <citation>Karim YM, Swanson DE. Comparison of blind tracheal intubation through the intubating laryngeal mask airway (LMA Fastrach™) and the Air-Q™. Anaesthesia. 2011 Mar;66(3):185-90. doi: 10.1111/j.1365-2044.2011.06625.x.</citation>
    <PMID>21320087</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 28, 2020</study_first_submitted>
  <study_first_submitted_qc>June 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2020</study_first_posted>
  <last_update_submitted>June 28, 2020</last_update_submitted>
  <last_update_submitted_qc>June 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Heba Mohamed EL -Asser,MD</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

